Copiktra: payments to doctors
Payments that named Copiktra as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $4.1M
- Providers
- 2,518
- Transactions
- 7,569
- Average per transaction
- $536
The per-transaction average — $536 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,518 providers the average total is $1,613, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Verastem, Inc. | $1,673,902 | 41.2% |
| Secura BIO, Inc. | $1,593,902 | 39.3% |
| Secura Bio, Inc. | $792,545 | 19.5% |